Patricia D. Kroboth - Publications

University of Pittsburgh, Pittsburgh, PA, United States 
Pharmacology, Pharmacy, Pharmaceutical Chemistry

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Poloyac SM, Empey KM, Rohan LC, Skledar SJ, Empey PE, Nolin TD, Bies RR, Gibbs RB, Folan M, Kroboth PD. Core competencies for research training in the clinical pharmaceutical sciences. American Journal of Pharmaceutical Education. 75: 27. PMID 21519417  0.48
2009 Bigos KL, Folan MM, Jones MR, Haas GL, Kroboth FJ, Kroboth PD. Dysregulation of neurosteroids in obsessive compulsive disorder. Journal of Psychiatric Research. 43: 442-5. PMID 18514738 DOI: 10.1016/j.jpsychires.2008.04.007  0.64
2007 Tortorici MA, Skledar SJ, Zemaitis MA, Weber RJ, Smith RB, Kroboth PD, Poloyac SM. A model for supporting and training clinical pharmaceutical scientist PhD students. American Journal of Pharmaceutical Education. 71: 32. PMID 17533441  0.64
2006 Fabian TJ, Schwartzman DS, Ujhelyi MR, Corey SE, Bigos KL, Pollock BG, Kroboth PD. Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam. Journal of Cardiovascular Electrophysiology. 17: 391-5. PMID 16643361 DOI: 10.1111/j.1540-8167.2006.00416.x  0.48
2004 Riechman SE, Fabian TJ, Kroboth PD, Ferrell RE. Steroid sulfatase gene variation and DHEA responsiveness to resistance exercise in MERET. Physiological Genomics. 17: 300-6. PMID 15152080 DOI: 10.1152/physiolgenomics.00097.2003  0.48
2004 Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Corey SE, Begley AE, Bensasi SG, Weber E, Dew MA, Reynolds CF, Pollock BG. Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Archives of Internal Medicine. 164: 327-32. PMID 14769630 DOI: 10.1001/archinte.164.3.327  0.48
2003 Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Reynolds CF, Pollock BG. Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Journal of Geriatric Psychiatry and Neurology. 16: 160-4. PMID 12967059 DOI: 10.1177/0891988703255689  0.48
2003 Kroboth PD, Amico JA, Stone RA, Folan M, Frye RF, Kroboth FJ, Bigos KL, Fabian TJ, Linares AM, Pollock BG, Hakala C. Influence of DHEA administration on 24-hour cortisol concentrations. Journal of Clinical Psychopharmacology. 23: 96-9. PMID 12544381 DOI: 10.1097/00004714-200302000-00014  0.48
2002 Lee JI, Chaves-Gnecco D, Amico JA, Kroboth PD, Wilson JW, Frye RF. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping. Clinical Pharmacology and Therapeutics. 72: 718-28. PMID 12496753 DOI: 10.1067/mcp.2002.129068  0.48
2002 Bies RR, Gastonguay MR, Coley KC, Kroboth PD, Pollock BG. Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 10: 696-705. PMID 12427578 DOI: 10.1097/00019442-200211000-00008  0.48
2002 Salek FS, Bigos KL, Kroboth PD. The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies. Journal of Clinical Pharmacology. 42: 247-66. PMID 11865961  0.64
2001 Fabian TJ, Dew MA, Pollock BG, Reynolds CF, Mulsant BH, Butters MA, Zmuda MD, Linares AM, Trottini M, Kroboth PD. Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biological Psychiatry. 50: 767-74. PMID 11720695 DOI: 10.1016/S0006-3223(01)01198-2  0.48
2001 Folan MM, Stone RA, Pittenger AL, Stoffel JA, Hess MM, Kroboth PD. Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patients. Critical Care Medicine. 29: 965-70. PMID 11378605 DOI: 10.1097/00003246-200105000-00012  0.48
2000 Frye RF, Kroboth PD, Kroboth FJ, Stone RA, Folan M, Salek FS, Pollock BG, Linares AM, Hakala C. Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults. Journal of Clinical Pharmacology. 40: 596-605. PMID 10868310  0.64
2000 Bonate PL, Kroboth PD, Smith RB, Suarez E, Oo C. Clonazepam and sertraline: absence of drug interaction in a multiple-dose study. Journal of Clinical Psychopharmacology. 20: 19-27. PMID 10653204  0.64
1999 Kroboth PD, Salek FS, Stone RA, Bertz RJ, Kroboth FJ. Alprazolam increases dehydroepiandrosterone concentrations. Journal of Clinical Psychopharmacology. 19: 114-24. PMID 10211912  0.64
1999 Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEA-S: a review. Journal of Clinical Pharmacology. 39: 327-48. PMID 10197292  0.64
1998 Kroboth PD, Folan MM, Bauer KS, Tullock W, Wright CE, Sweeney JA. Do alprazolam-induced changes in saccadic eye movement and psychomotor function follow the same time course? Journal of Clinical Pharmacology. 38: 337-46. PMID 9590461  0.48
1998 Gleason PP, Schulz R, Smith NL, Newsom JT, Kroboth PD, Kroboth FJ, Psaty BM. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. Journal of General Internal Medicine. 13: 243-50. PMID 9565387 DOI: 10.1046/j.1525-1497.1998.00074.x  0.36
1997 Bertz RJ, Kroboth PD, Kroboth FJ, Reynolds IJ, Salek F, Wright CE, Smith RB. Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects. The Journal of Pharmacology and Experimental Therapeutics. 281: 1317-29. PMID 9190868  0.48
1997 Sweeney JA, Bauer KS, Keshavan MS, Haas GL, Schooler NR, Kroboth PD. Adverse effects of risperidone on eye movement activity: a comparison of risperidone and haloperidol in antipsychotic-naive schizophrenic patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 16: 217-28. PMID 9138438 DOI: 10.1016/S0893-133X(96)00195-9  0.48
1996 McAuley JW, Kroboth FJ, Kroboth PD. Oral administration of micronized progesterone: a review and more experience. Pharmacotherapy. 16: 453-7. PMID 8726605  0.36
1995 Kroboth PD, Folan MM, Lush RM, Chaikin PC, Shukla UA, Barbhaiya R, Salazar DE. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment. Journal of Clinical Psychopharmacology. 15: 306-19. PMID 8830061  0.48
1995 Bertz RJ, Reynolds IJ, Kroboth PD. Effect of neuroactive steroids on [3H]flumazenil binding to the GABAA receptor complex in vitro. Neuropharmacology. 34: 1169-75. PMID 8532187 DOI: 10.1016/0028-3908(95)00072-E  0.48
1995 McAuley JW, Reynolds IJ, Kroboth FJ, Smith RB, Kroboth PD. Orally administered progesterone enhances sensitivity to triazolam in postmenopausal women. Journal of Clinical Psychopharmacology. 15: 3-11. PMID 7714225 DOI: 10.1097/00004714-199502000-00002  0.48
1995 Derry CL, Kroboth PD, Pittenger AL, Kroboth FJ, Corey SE, Smith RB. Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men Journal of Clinical Psychopharmacology. 15: 197-205. PMID 7635997 DOI: 10.1097/00004714-199506000-00008  0.48
1995 Kroboth PD, McAuley JW, Kroboth FJ, Bertz RJ, Smith RB. Triazolam pharmacokinetics after intravenous, oral, and sublingual administration. Journal of Clinical Psychopharmacology. 15: 259-62. PMID 7593708  0.64
1993 McAuley JW, Kroboth PD, Stiff DD, Reynolds IJ. Modulation of [3H]flunitrazepam binding by natural and synthetic progestational agents. Pharmacology, Biochemistry, and Behavior. 45: 77-83. PMID 8516376 DOI: 10.1016/0091-3057(93)90089-C  0.48
1993 Kroboth PD, Bertz RJ, Smith RB. Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant. The Journal of Pharmacology and Experimental Therapeutics. 264: 1047-55. PMID 8450449  0.64
1993 Smith RB, Kroboth PD, Folan MM, Kroboth FJ, Rosanske TW. Design and pharmacodynamic evaluation of novel dual release formulations of triazolam. International Journal of Clinical Pharmacology, Therapy, and Toxicology. 31: 422-9. PMID 8225690  0.64
1992 Schmith VD, Piraino B, Smith RB, Kroboth PD. Alprazolam in end-stage renal disease. II. Pharmacodynamics. Clinical Pharmacology and Therapeutics. 51: 533-40. PMID 1587068 DOI: 10.1038/clpt.1992.59  0.64
1991 Kroboth PD, Schmith VD, Smith RB. Pharmacodynamic modelling. Application to new drug development. Clinical Pharmacokinetics. 20: 91-8. PMID 2029808 DOI: 10.2165/00003088-199120020-00001  0.64
1991 Schmith VD, Piraino B, Smith RB, Kroboth PD. Alprazolam in end-stage renal disease: I. Pharmacokinetics. Journal of Clinical Pharmacology. 31: 571-9. PMID 1880224  0.64
1991 Schmith VD, Cox SR, Zemaitis MA, Kroboth PD. New high-performance liquid chromatographic method for the determination of alprazolam and its metabolites in serum: instability of 4-hydroxyalprazolam Journal of Chromatography B: Biomedical Sciences and Applications. 568: 253-260. PMID 1770105 DOI: 10.1016/0378-4347(91)80361-F  0.48
1990 Kroboth PD, McAuley JW, Smith RB. Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing. Psychopharmacology. 100: 477-84. PMID 2320708  0.64
1988 Kroboth PD, Smith RB, Erb RJ. Tolerance to alprazolam after intravenous bolus and continuous infusion: Psychomotor and EEG effects Clinical Pharmacology and Therapeutics. 43: 270-277. PMID 3345619  0.48
1987 Smith RB, Kroboth PD, Juhl RP. The clinical pharmacist in drug research and development. An academic-industrial center. Drug Intelligence & Clinical Pharmacy. 21: 127-9. PMID 3816573  1
1987 Juhl RP, Kroboth PD. Conceptual issues in designing a clinical scientist program. Drug Intelligence & Clinical Pharmacy. 21: 103-6. PMID 3816565  1
1987 Kroboth PD, Smith RB, Van Thiel DH, Juhl RP. Nighttime dosing of triazolam in patients with liver disease and normal subjects: kinetics and daytime effects. Journal of Clinical Pharmacology. 27: 555-60. PMID 3655006  1
1987 Silver MR, Kroboth PD. Pentoxifylline in end-stage renal disease. Drug Intelligence & Clinical Pharmacy. 21: 976-8. PMID 3428162  0.36
1985 Kroboth PD, Smith RB, Stoehr GP, Juhl RP. Pharmacodynamic evaluation of the benzodiazepine-oral contraceptive interaction. Clinical Pharmacology and Therapeutics. 38: 525-32. PMID 2865026 DOI: 10.1038/clpt.1985.218  1
1985 Kroboth PD, Smith RB, Silver MR, Rault R, Sorkin MI, Puschett JB, Juhl RP. Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics. British Journal of Clinical Pharmacology. 19: 839-42. PMID 2862896  1
1985 Kroboth PD, Smith RB, Rault R, Silver MR, Sorkin MI, Puschett JB, Juhl RP. Effects of end-stage renal disease and aluminum hydroxide on temazepam kinetics. Clinical Pharmacology and Therapeutics. 37: 453-9. PMID 2858279  1
1984 Smith RB, Kroboth PD, Vanderlugt JT, Phillips JP, Juhl RP. Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration. Psychopharmacology. 84: 452-6. PMID 6152055  1
1984 Juhl RP, Daugherty VM, Kroboth PD. Incidence of next-day anterograde amnesia caused by flurazepam hydrochloride and triazolam. Clinical Pharmacy. 3: 622-5. PMID 6150782  1
1984 Stoehr GP, Kroboth PD, Juhl RP, Wender DB, Phillips JP, Smith RB. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics. Clinical Pharmacology and Therapeutics. 36: 683-90. PMID 6149030 DOI: 10.1038/clpt.1984.240  1
1984 Kroboth PD, Smith RB, Sorkin MI, Silver MR, Rault R, Garry M, Juhl RP. Triazolam protein binding and correlation with alpha-1 acid glycoprotein concentration. Clinical Pharmacology and Therapeutics. 36: 379-83. PMID 6147221  1
1983 Kroboth PD, Juhl RP. New drug evaluations. Triazolam. Drug Intelligence & Clinical Pharmacy. 17: 495-500. PMID 6135590  1
1982 Kroboth PD, Brown A, Lyon JA, Kroboth FJ, Juhl RP. Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects. Antimicrobial Agents and Chemotherapy. 21: 135-40. PMID 7081971 DOI: 10.1128/aac.21.1.135  1
Show low-probability matches.